Literature DB >> 8793265

A decrease in antiphospholipid antibodies before a thrombotic event.

S Praprotnik1, B Bozic.   

Abstract

We are reporting a systemic lupus erythematosus patient with antiphospholipid syndrome who developed iliofemoral thrombosis. Before the occurrence of iliofemoral venous thrombosis, antiphospholipid antibodies (aPL) gradually decreased over a period of 18 weeks but were within normal range during its acute phase. In the course of two years following this case of thrombosis, aPL have never returned to the high prethrombotic values. It is therefore most likely that aPL were involved in the process of provoking thrombosis rather than being consumed during its acute phase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8793265     DOI: 10.1007/bf02229712

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  7 in total

Review 1.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

Review 2.  Antiphospholipid antibodies and thrombosis. A consequence, coincidence, or cause?

Authors:  D A Triplett
Journal:  Arch Pathol Lab Med       Date:  1993-01       Impact factor: 5.534

Review 3.  Clinical trials on antiphospholipid syndrome: what is being done and what is needed?

Authors:  T Barbui; G Finazzi
Journal:  Lupus       Date:  1994-08       Impact factor: 2.911

4.  Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.

Authors:  M Blank; J Cohen; V Toder; Y Shoenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Anticardiolipin antibodies in patients with systemic lupus erythematosus.

Authors:  G Sturfelt; O Nived; R Norberg; R Thorstensson; K Krook
Journal:  Arthritis Rheum       Date:  1987-04

6.  Fall in antiphospholipid antibody at time of thromboocclusive episodes in systemic lupus erythematosus.

Authors:  C Drenkard; J Sánchez-Guerrero; D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1989-05       Impact factor: 4.666

7.  Anticardiolipin wet workshop report. Fifth International Symposium on antiphospholipid antibodies.

Authors:  E N Harris; S Pierangeli; D Birch
Journal:  Am J Clin Pathol       Date:  1994-05       Impact factor: 2.493

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.